Bal Pharma Ltd Quarterly Results

Gross Sales

81.88

73.15

73.69

74.36

94.63

Excise Duty

0

0

0

0

0

Net Sales

81.88

73.15

73.69

74.36

94.63

Other Operating Income

0

0

0

0

0

Other Income

1.08

0.51

-0.2

0.82

2.45

Total Income

82.96

73.66

73.49

75.18

97.08

Total Expenditure

74.24

65.4

66

67.89

85.03

PBIDT

8.72

8.26

7.49

7.28

12.05

Interest

3.95

5.01

3.65

4.24

4.14

PBDT

4.77

3.25

3.84

3.05

7.91

Depreciation

2.18

2.69

2.48

2.43

2.16

Minority Interest Before NP

0

0

0

0

0

Tax

-1.3

0.14

0.47

0.55

-1.43

Deferred Tax

-1.52

-0.1

-0.15

-0.19

1.64

Reported Profit After Tax

5.42

0.52

1.04

0.26

5.53

Minority Interest After NP

-0.02

0.04

0

0

0.06

Net Profit after Minority Interest

5.43

0.48

1.04

0.26

5.47

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

5.43

0.48

1.04

0.26

5.47

EPS (Unit Curr.)

3.4

0.33

0.65

0.16

3.73

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

15.92

15.92

15.92

15.8

15.8

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

10.64

11.29

10.16

9.79

12.73

PBDTM(%)

5.82

4.44

5.21

4.1

8.35

PATM(%)

6.61

0.71

1.41

0.34

5.84